US Bancorp
ADAP

US Bancorp’s Adaptimmune Therapeutics ADAP Stock Holding History

Quarter Market Value Status Shares Shares
Change %
Trade Value Portfolio Weight Portfolio Position
2023
Q4
Sell
-1,058
Closed -$825 3942
2023
Q3
$825 Hold
1,058
﹤0.01% 3774
2023
Q2
$979 Buy
+1,058
New +$979 ﹤0.01% 3776
2022
Q4
Sell
-16,049
Closed -$18K 4107
2022
Q3
$18K Buy
16,049
+14,939
+1,346% +$16.8K ﹤0.01% 3045
2022
Q2
$2K Sell
1,110
-9,367
-89% -$16.9K ﹤0.01% 3763
2022
Q1
$22K Buy
10,477
+6,028
+135% +$12.7K ﹤0.01% 2999
2021
Q4
$17K Sell
4,449
-1,280
-22% -$4.89K ﹤0.01% 3170
2021
Q3
$29K Buy
5,729
+4,590
+403% +$23.2K ﹤0.01% 2909
2021
Q2
$5K Sell
1,139
-188
-14% -$825 ﹤0.01% 3569
2021
Q1
$7K Sell
1,327
-109
-8% -$575 ﹤0.01% 3379
2020
Q4
$7K Sell
1,436
-471
-25% -$2.3K ﹤0.01% 3268
2020
Q3
$15K Buy
1,907
+549
+40% +$4.32K ﹤0.01% 2879
2020
Q2
$14K Sell
1,358
-615
-31% -$6.34K ﹤0.01% 2903
2020
Q1
$5K Buy
+1,973
New +$5K ﹤0.01% 3160